1175021

Jean-Jacques Kiladjian, M.D., PhD — FEI 3021934427

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Paris (France)

Additional Details

Clinical Investigator (CI)